Changes in Serum TSH Receptor Antibody (TRAb) Values in Patients with Graves' Disease after Total or Subtotal Thyroidectomy

Endocrine Journal

Volumn 50, Issue 5, 2003, Pages 595-601

  Takamura, Yuuki ^a   Nakano, Keiichi ^a   Uruno, Takashi ^a   Ito, Yasuhiro ^a   Miya, Akihiro ^a   Kobayashi, Kaoru ^a   Yokozawa, Tamotsu ^a   Matsuzuka, Fumio ^a   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Graves' disease; Surgery; Total thyroidectomy; TRAb

Indexed keywords

THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; GRAVES DISEASE; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; FEMALE; GRAVES DISEASE; HUMANS; HYPOPARATHYROIDISM; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RECEPTORS, THYROTROPIN; THYROIDECTOMY;

EID: 10744224983     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.595     Document Type: Article

References (39)

1. Cooper DS (2000) Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD (eds) The Thyroid (8th ed). Lippincott, Philadelphia, PA. 691-715.
2. McIver B, Morris JC (1998) The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am 27: 73-89.
3. Okamoto T, Fujimoto Y, Obara T, Ito Y, Aiba M (1992) Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease. World J Surg 16: 690-696.
4. Mori Y, Matoba N, Miura S, Sakai N, Taira Y (1992) Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease. World J Surg 16: 647-653.
5. Winsa B, Rastad J, Akerstrom G, Johansson H, Westermark K, Karlsson FA (1995) Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine opthalmopathy. Eur J Endocrinol 132: 406-412.
6. Jacobson DH, Gorman CA (1984) Endocrine opthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr Rev 5: 200-220.
7. Cove DH, Johnston P (1985) Fetal hyperthyroidism: experience of treatment in four siblings. Lancet 1: 430-432.
8. Polak M, Leger J, Luton D, Oury JF, Vuillard E, Boissinot C, Czernichow P (1997) Fetal cord blood sampling in the diagnosis and the treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother, producing thyroid stimulating immunoglobulins. Ann Endocrinol (Paris) 58: 338-342.
9. Chopra IJ (1992) Fetal and neonatal hyperthyroidism. Thyroid 2: 161-163.
10. Foley TP (1991) Maternally transferred thyroid disease in the infant: recognition and treatment. In: Bercu BB and Shulman DI (eds) Advances in Perinatal Thyroidology. Plenum Press, New York, NY. 209-226.
11. Mckenzie JM, Zakarija M (1992) Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2: 155-159.
12. Yamashita Y, Yamane K, Fujiwara R, Okubo M, Kohno N (2002) A successful pregnancy and delivery case of Graves' disease with myeloperoxidase anti-neutrophil cytoplasmic antibody induce by propylthiouracil. Endocr J 49: 555-559.
13. Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Fukata S, Tamai H, Miyauchi A, Sugawara M (1991) Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction. Am J Med Sci 302: 8-12.
14. Palit TK, Miller CC, Miltenburg DM (2000) The efficacy of thyroidectomy for Graves' disease: a meta-analysis. J Surg Res 90: 161-165.
15. Sugino K, Mimura T, Ozaki O, Kure Y, Iwasaki H, Wada N, Matsumoto A, Ito K (1995) Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy. World J Surg 19: 648-652.
16. Steel NR, Taylor JJ, Young ET, Farndon JR, Holcombe M, Kendall-Taylor P (1987) The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease. Clin Endocrinol 26: 97-106.
17. Teng CS, Yeung RT, Khoo RK, Alagaratnam TT (1980) A prospective study of changes in thyrotropin binding inhibitory immunoglobulin in Graves' disease treated by subtotal thyroidectomy or radioactive iodine. J Clin Endocrinol Metab 50: 1005-1010.
18. De Bruin TWA, Patwardhan AN, Brown SR, Braverman EL (1988) Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy. Clin Exp Immunol 72: 481-485.
19. Mukhtar ED, Smith BR, Pyle GA, Hall R, Vice P (1975) Relation of thyroid stimulating immunoglobulins to thyroid function and effects of surgery, radio-iodine, and antithyroid drugs. Lancet 1: 713-715.
20. Smith BR, Mukhtar GA, Pyle P, Kendall-Taylor P, Hall R (1976) Thyroid-stimulating immunoglobulins and hyperthyroidism in Graves' disease. In: Thyroid Research. Excerpta Medica, Amsterdam, 411.
21. Hosojima H, Miyauchi E, Okada H, Azukizawa S, Yamamoto I, Morimoto S (1990) Changes in TSH-receptor (TR-AB) and thyroid stimulating antibodies (TS-AB) after thyroidectomy in thyrotoxic patients. Folia Endocrinol 66: 727.
22. Sugino K, Mimura T, Toshima K, Iwabuchi H, Kitamura Y, Kawano M, Ozaki O, Ito K (1993) Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for postoperative thyroid dysfunction. J Endocrinol Invest 16: 195-199.
23. Sugino K, Mimura T, Ozaki O, Iwasaki H, Wada N, Matsumoto A, Ito K (1996) Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy. World J Surg 20: 801-807.
24. Yamashita H, Noguchi S, Murakami N, Watanabe S, Kawamoto H (1998) Post-operative thyroid status of patients with Graves' disease is determined by the responsiveness of thyrocyte to TSH under the present thyroid gland remnant. Endocr J 45: 513-517.
25. Perzik SL (1976) The place of total thyroidectomy in the management of 909 patients with thyroid disease. Am J Surg 132: 480-483.
26. Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A (1996) Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery 120: 1020-1025.
27. Hermann M, Roka R, Richter B, Freissmuth M (1998) Early relapse after operation for Graves' disease: post-operative hormone kinetics and outcome after subtotal, near-total, and total thyroidectomy. Surgery 124: 894-900.
28. Mandel SJ, Cooper DS (2001) The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86: 2354-2359.
29. Momotani N (1999) Diagnosis and treatment of autoimmune thyroid disease (ATD) complicated by pregnancy. Nippon Rinsho 57: 1866-1872 (In Japanese, abstract in English).
30. Smith C, Thomsett M, Choong C, Rodda C, McIntyre HD, Cotterill AM (2001) Congenital thyrotoxicosis in premature infants. Clin Endocrinol (Oxf) 54: 371-376.
31. Smith BR, McLachlan SM, Furmanak J (1988) Auto-antibodies to the thyrotropin receptor. Endocr Rev 9: 106.
32. Kasagi K, Iida Y, Konishi J, Misaki T, Arai K, Endo K, Torizuka K, Kuma K (1986) Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment. Acta Endocrinol (Copenh) 111: 474-480.
33. Docter R, Bos G, Visser TJ, Hannemann G (1980) Thyrotropin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator. Clin Endocrinol (Oxf) 12: 143-153.
34. Paschke R, Heinze HG, Teuber J, Schmeidl R, Usadel KH (1987) Extrathyroidal synthesis and biologic action of thyroid receptor antibody (TRAb) in Graves' disease. Acta Endocrinol Suppl (Copenh) 281: 352-354.
35. Menegaux F, Ruprecht T, Chigot JP (1993) The surgical treatment of Graves' disease. Surg Gynecol Obstet 176: 277-282.
36. Kasuga Y, Sugenoya A, Kobayashi S, Kaneko G, Masuda H, Fujimoto M, Iida F (1990) Clinical evaluation of the response to surgical treatment of Graves' disease. Surg Gynecol Obstet 170: 327-330.
37. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K (1992) Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab 75: 738-744.
38. Mortimer RH, Tyack SA, Galigan JP, Perry-Keene DA, Tan YM (1990) Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Clin Endocrinol (Oxf) 32: 141-152.
39. Kurihara H (2002) Total thyroidectomy for treatment of hyperthyroidism in patients with opthalmopathy. Thyroid 12: 265-267.